FDA Expectations for 503B Outsourcing Facilities, New Webinar Hosted by Xtalks
/EINPresswire.com/ -- TORONTO, ON--(Marketwired - December 01, 2015) - On Friday, December 11, 2015 at 1pm EST, industry expert Doyle Smith, Compliance Specialist at Compliance Insight, Inc., will give a discussion on preparing for FDA Section 503B. This segment will aid compounding pharmacies considering whether to register with the FDA as an Outsourcing Facility. It will also benefit outsourcing pharmacies that are wondering why so many 503B facilities are receiving FDA Warning Letters.
The webinar will address the most pressing issues affecting the Compounding Pharmacy/Outsourcing Industry such as:
- FDA 483/Warning Letters
- Sterile Area Expectations
- Quality System
- Standard Operating Procedures
- Quality Training
- 503B Registration Filing
- Process/Equipment Validation
This complimentary one-hour session will include a Q&A with the audience. For more information or registration visit: FDA Expectations for 503B Outsourcing Facilities
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2015/11/30/11G073924/Images/Compliance_new_logo-89669589463.jpg
Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com
Compliance Insight offers hands-on compliance, quality assurance, clinical and regulatory affairs guidance and consulting that is reliable, accurate, timely and supportive of the client's goals and compliant with US FDA Regulations.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
